Price $221.15 |
Market Cap
14.72B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
41.9
|
P/B
4.15
|
P/S
3.97
|
Dividend %
-
|
|
P/CF
208.0
|
P/FCF
25.0
|
Op. Cash Flow
862.9K
|
FCF
7.9
|
|
Op. Margin
14.80%
|
Net Margin
8.30%
|
ROE
8.70%
|
ROI
11.20%
|
|
ROA
5.30%
|
EPS Growth
-48.20%
|
Current Ratio
1.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.39 | - | - | 8.13B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
